12:00 AM
Aug 15, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Tuberculosis vaccine: Phase IIb started

The Oxford-Emergent Tuberculosis Consortium Ltd., a JV between Emergent and University of Oxford (Oxford, U.K.), and not-for-profit Aeras Global TB Vaccine Foundation (Rockville, Md.) began a double-blind, placebo-controlled, African...

Read the full 134 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >